Protective effects ofLactobacillus paracaseiF19 in a rat model of oxidative and metabolic hepatic injury

Abstract

The liver is susceptible to such oxidative and metabolic stresses as ischemia-reperfusion (I/R) and fatty acid accumulation. Probiotics are viable microorganisms that restore the gut microbiota and exert a beneficial effect on the liver by inhibiting bacterial enzymes, stimulating immunity, and protecting intestinal permeability. We evaluated Lactobacillus paracasei F19 (LP-F19), for its potential protective effect, in an experimental model of I/R (30 min ischemia and 60 min reperfusion) in rats fed a standard diet or a steatogen [methionine/choline-deficient (MCD)] diet. Both groups consisted of 7 sham-operated rats, 10 rats that underwent I/R, and 10 that underwent I/R plus 8 wk of probiotic dietary supplementation. In rats fed a standard diet, I/R induced a decrease in sinusoid perfusion ( P < 0.001), severe liver inflammation, and necrosis besides an increase of tissue levels of malondialdehyde ( P < 0.001), tumor necrosis factor-α ( P < 0.001), interleukin (IL)-1β ( P < 0.001), and IL-6 ( P < 0.001) and of serum levels of transaminase ( P < 0.001) and lipopolysaccharides ( P < 0.001) vs. sham-operated rats. I/R also induced a decrease in Bacterioides , Bifidobacterium , and Lactobacillus s pps ( P < 0.01, P < 0.001, and P < 0.001, respectively) and an increase in Enterococcus and Enterobacteriaceae ( P < 0.01 and P < 0.001, respectively) on intestinal mucosa. The severity of liver and gut microbiota alterations induced by I/R was even greater in rats with liver inflammation and steatosis, i.e., MCD-fed animals. LP-F19 supplementation significantly reduced the harmful effects of I/R on the liver and on gut microbiota in both groups of rats, although the effect was slightly less in MCD-fed animals. In conclusion, LP-F19 supplementation, by restoring gut microbiota, attenuated I/R-related liver injury, particularly in the absence of steatosis.